STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

Abroad (travel likely)RecruitingPHASE3

Conditions

Polycystic Kidney, Autosomal Dominant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Vorarlberger Krankenhaus-Betriebsgesellschaft, Feldkirch, Austria
Contact: Study coordinator (Emanuel Zitt, MD) · nephro@lkhf.at
Medizinische Universitaet Innsbruck, Innsbruck, Austria
Contact: Study coordinator (Michael Rudnicki, Prof.) · michael.rudnicki@i-med.ac.at
Robert Bosch Gesellschaft für Medizinische Forschung mbH, Stuttgart, Baden-Wurttemberg, Germany
Contact: Study coordinator (Joerg Latus, Prof.) · andrea.schwab@rbk.de · +4971181015874
Klinikum Nürnberg, Nuremberg, Bavaria, Germany
Contact: Study coordinator (Christian Morath, Prof.) · +499113982702
Universitaetsklinikum Aachen AöR, Aachen, Germany
Contact: Study coordinator (Susanne Fleig, MD) · SekretariatMK2@ukaachen.de
Charite Universitaetsmedizin Berlin KöR, Berlin, Germany
Contact: Study coordinator (Eva Vanessa Schrezenmeier, Dr) · nephrologie-studien@charite.de
Universitätsklinikum Köln, Cologne, Germany
Contact: Study coordinator (Malte Bartram, Dr.) · studienzentrum-medII@uk-koeln.de
Klinikum Dortmund gGmbH, Dortmund, Germany
Contact: Study coordinator (Fedai Özcan, MD) · studienzentrum@klinikumdo.de
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR, Dresden, Germany
Contact: Study coordinator (Alexander Paliege, MD) · alexander.paliege@ukdd.de
Universitaetsklinikum Duesseldorf AöR, Düsseldorf, Germany
Contact: Study coordinator (Roman-Ulrich Mueller, Prof.) · studienzentrum-nephrologie@med.uni-duesseldorf.de
Goethe University Frankfurt, Frankfurt, Germany
Contact: Study coordinator (Jeannine Lang, MD) · sekretariat.nephrologie@unimedizin-ffm.de
Medical Center - University of Freiburg, Freiburg im Breisgau, Germany
Contact: Study coordinator (Jan Halbritter, Prof.) · jan.halbritter@uniklinik-freiburg.de · +4976127032510
Universitaetsmedizin Goettingen, Göttingen, Germany
Contact: Study coordinator (Oliver Gross, Prof.) · nephrorheuma.ambulanz@med.uni-goettingen.de
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Contact: Study coordinator (Fabian Braun, MD) · nierenambulanz@uke.de
Medizinische Hochschule Hannover, Hanover, Germany
Contact: Study coordinator (Jessica Kaufeld, MD) · studienzentrum@mh-hannover.de
Zentrum Fuer Nieren Hochdruck Und Stoffwechselerkrankungen, Hanover, Germany
Contact: Study coordinator (Georg Schlieper, MD) · Ambulanz.Heidering@dialyse-hannover.de
Universitaetsklinikum Heidelberg AöR, Heidelberg, Germany
Contact: Study coordinator (Claudia Sommerer, Prof.) · Studienzentrum-Nephrologie.MED10@med.uni-heidelberg.de
Universitaetsklinikum Jena KöR, Jena, Germany
Contact: Study coordinator (Martin Busch, Prof.) · kim3-nephroambulanz@med.uni-jena.de
Universitaetsklinikum Schleswig-Holstein AöR, Kiel, Germany
Contact: Study coordinator (Roland Schmitt, Prof.) · studienzentrum.nephrologie.kiel@uksh.de
Universitaet Leipzig, Leipzig, Germany
Contact: Study coordinator (Friederike Petzold, MD) · nephrologieambulanz@medizin.uni-leipzig.de
Universitaetsklinikum Schleswig-Holstein AöR, Lübeck, Germany
Contact: Study coordinator (Figen Cakiroglu, MD) · Franziska.Klingbiel@uksh.de
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz, Germany
Contact: Study coordinator (Julia Weinmann-Menke, Prof.) · julia.weinmann-menke@unimedizin-mainz.de
Klinikum der Technischen Universitaet Muenchen, München, Germany
Contact: Study coordinator (Lutz Renders, Prof.) · nephrologie.office@mri.tum.de
LMU Klinikum Muenchen AöR, München, Germany
Contact: Study coordinator (Michael Fischereder, Prof.) · NephroStudien-GH@med.uni-muenchen.de
Klinikum Der Landeshauptstadt Stuttgart gKAöR, Stuttgart, Germany
Contact: Study coordinator (Markus Krautter, Dr.) · m.krautter@klinikum-stuttgart.de
Universitair Medisch Centrum Groningen, Groningen, Netherlands
Contact: Study coordinator (Ron Gansevoort, Prof.) · researchnefrologie@int.umcg.nl
Leids Universitair Medisch Centrum, Leiden, Netherlands
Contact: Study coordinator (Siebe Spijker, MD) · researchcoordinator_krig_int@lumc.nl
Erasmus Universitair Medisch Centrum Rotterdam, Rotterdam, Netherlands
Contact: Study coordinator (Mahdi Salih, MD) · tb.ig@erasmusmc.nl
Fundacio Hospital Universitari Vall D'Hebron Institut De Recerca, Barcelona, Spain
Contact: Study coordinator (Laia Sans Axter, MD) · assajos.nefrologia@vhir.org
Fundacio Puigvert, Barcelona, Spain
Contact: Study coordinator (Roser Torra Balcells, Prof.) · ofgrin@fundacio-puigvert.es

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

ADPKD

Abroad (travel likely)RecruitingPHASE3

Brussels, Belgium · Leuven, Belgium

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Garden Grove, United States · Huntington Park, United States

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Zurich, Switzerland · Chur, Switzerland

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Autosomal Dominant Polycystic Kidney · Obesity

Abroad (travel likely)RecruitingPHASE2

Aurora, United States